Breaking News

Syneos Health, uMotif Partner on Patient-centric eClinical Platform

Alliance aims to accelerate clinical trials through a more efficient, end-to-end digital platform that includes eCOA and ePRO.

Syneos Health, a fully integrated biopharmaceutical solutions organization, entered into a strategic partnership with uMotif, a clinical trial technology company. The collaboration aims to accelerate clinical trials through a more efficient, end-to-end digital platform that includes robust Electronic Clinical Outcome Assessment (eCOA) and Electronic Patient-reported Outcomes (ePRO) capabilities.

In addition to uMotif providing eCOA and ePRO services for Syneos Health customers, the companies will develop and deploy an exclusive patient-centric platform to deliver integrated customer solutions – including patient identification, recruitment, eConsent, eDiary, patient engagement and retention, and payments. Complemented by the Company’s StudyKIK recruitment technology platform, Syneos Health will build a single application to help drive better engagement, compliance, and retention with patients, and reduce site burden.

“At Syneos Health, we are constantly evolving our solutions to address unmet customer, site and patient needs,” said Michael Brooks, Chief Operating Officer, Syneos Health. “The partnership with uMotif is a natural fit as both companies share a forward-thinking approach to technology and are committed to the site and patient experience.” Brooks added, “We’re excited to collaborate with uMotif to deliver an integrated, best-in-class, patient-facing solution to bring clinical trials closer to the patient.”

The uMotif cloud-native and highly configurable platform is collaboratively designed with patients, healthcare professionals, monitors, data managers and sponsors. The platform can be quickly adapted to meet protocol specific requirements, providing optimal flexibility for sponsors, sites, and patients.

“We’re excited to work with Syneos Health. We believe our modern, patient-centric solution is aligned with Syneos Health’s vision of creating a better patient experience and providing sponsors with better trials,” said Steve Rosenberg, CEO, uMotif. “We also look forward to building a solution that leverages the power of StudyKIK’s patient identification, recruitment and retention technology platform and complements Syneos Health’s focus on patient centric solutions. Together, we are deploying a solution where patient workflow is made simple, easy, and effective – ensuring that participants are fully able and engaged to capture large volumes of data – to help maximize the success of a clinical trial.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters